Bengaluru, Karnataka, India, June 5, 2020
Biocon Ltd, an innovation-led global biopharmaceuticals company, is pleased to announce that its Executive Chairperson Kiran Mazumdar-Shaw has been named the EY World Entrepreneur of the Year™ 2020 (WEOY) at a virtual award ceremony held on late Thursday.
Kiran has been honoured with the world title from among a distinguished list of 46 EOY country award winners from 41 countries and territories. In EY World Award’s 20-year history, Kiran is the First Woman Entrepreneur from India and third Indian to win the EY World Entrepreneur of the Year Award. She is the Second woman worldwide to hold this prestigious title, following Olivia Lum of Hyflux Limited, Singapore, who won the award in 2011
Uday Kotak of Kotak Mahindra Bank (2014) and Narayana Murthy of Infosys Technologies Limited (2005) are the other world title winners from India.
Kiran has previously won the EY Best Entrepreneur: Healthcare & Life Sciences Award in 2002 and was bestowed with the EY Entrepreneur of the Year India 2019 Award in February 2020 and represented India at the WEOY 2020. In their felicitation, EY had said Kiran Mazumdar-Shaw is “synonymous with the Indian biotech industry,” and has been at the “forefront of innovation” through her strong investments in research.
On receiving the prestigious World title, Kiran Mazumdar-Shaw said: “I am truly honoured to receive the prestigious EY World Entrepreneur of the Year Award 2020. At its core, entrepreneurship is about solving problems. The greatest opportunities often arise at the toughest times, and that's been my experience throughout my entrepreneurial journey. My business focus is global health care and the provision of universal access to life saving medicine; however, my responsibility as an entrepreneur is greater than simply delivering value to shareholders. Wealth creation can be a catalyst for change, and all entrepreneurs have a responsibility to the world around them and the communities in which they operate. Right now, the world is looking for solutions to prevent infection with SARS-CoV-2 and treat patients with COVID-19. As the founder of a global biopharmaceutical company, I am contributing to worldwide efforts to tackle the novel coronavirus through innovative science.”
“Women also play a hugely important role in economic development, and for too long their contribution has been ignored. It's important that we use the platform of EY World Entrepreneur of the Year to encourage more women to participate in entrepreneurial pursuits,” she added.
*Manny Stul, Chairman and Co-CEO of Moose Toys and Chair of the EY World Entrepreneur of the Year judging panel said: “Kiran is an inspirational entrepreneur who demonstrates that determination, perseverance and a willingness to innovate can create long-term value. The judging panel were impressed by her ability to build and sustain growth over the past 30 years and by her integrity and passion for philanthropy that has delivered huge global impact. She has built India's largest biopharmaceutical company on a foundation of compassionate capitalism and putting patient needs before profits."
*Stasia Mitchell, EY Global Entrepreneurship Leader, said: “With an exceptional record in creating long-term value, Kiran’s clear vision of making a difference to the lives of millions of people around the world make her a worthy EY World Entrepreneur of the Year winner. Her impact on improving global health access and affordability will endure for decades to come. She is a beacon for other entrepreneurs to follow."
EY Entrepreneur Of The Year™ is the world’s most prestigious business awards program for unstoppable entrepreneurs. These visionary leaders deliver innovation, growth and prosperity that transform our world. The program engages entrepreneurs with insights and experiences that foster growth. It connects them with their peers to strengthen entrepreneurship around the world. EY Entrepreneur of the Year is the first and only truly global awards program of its kind. It celebrates entrepreneurs through regional and national awards programs in more than 145 cities in over 60 countries. Winners go on to compete for the EY World Entrepreneur Of The Year™ title.
Every year, an independent jury comprising of some of the world’s most eminent business leaders selects the finalists and winners of the program. This year’s judging panel was chaired by Manny Stul, Chairman and Co-CEO Moose Toys. Joining him were Rosaleen Blair, CBE, Founder and Chair of Alexander Mann Solution; George Hongchoy, Executive Director and CEO of Link Asset Management Limited; Hernan Kazah, Co-founder and Managing Partner of Kaszek Ventures; Sipho Nkosi, Chairman of Sasol; Emine Sabancı Kamışlı, Co-founder and Vice Chairperson od Esas Holdings.
*Source: EY Press Release
About Kiran Mazumdar-Shaw:
Kiran Mazumdar-Shaw is a pioneering biotech entrepreneur, a healthcare visionary, a global influencer, and a passionate philanthropist. Founder of Biocon, an innovation-led global biopharmaceuticals enterprise, her vision and work have drawn global recognition both for Indian industry and her company.
Named among Time’s 100 most influential people in the world and Forbes’ 100 most powerful women, Kiran has been pivotal in redefining the biotechnology landscape through Biocon’s initiatives and breaking new ground through her philosophy of ensuring affordable access to life-saving biopharmaceuticals globally.
Her inspiring achievements have earned her several coveted titles and awards, both national and international. She has been recognized with two of India’s highest civilian honours, the Padma Shri (1989) and the Padma Bhushan (2005). She has been conferred with the Order of Australia, Australia’s highest civilian honour, in 2020 and appointed Knight of the National Order of the French Legion of Honour in 2016.
In 2014, she was honoured with the Othmer Gold Medal by the U.S.-based Chemical Heritage Foundation. The same year, the Kiel Institute for the World Economy, Germany, awarded her the Global Economy Prize.
Kiran holds key positions in various industry, educational, government and professional bodies. She was elected full-term member of the Board of Trustees of the prestigious Massachusetts Institute of Technology (MIT), U.S., in 2018 and as a Member of the National Academy of Engineering, U.S., in 2019.
She is also among the earliest Indian signatories to the Giving Pledge, a global commitment to dedicate majority of her wealth to philanthropy.
About Biocon Ltd:
Biocon Limited, publicly listed in 2004, (BSE code: 532523, NSE Id: BIOCON, ISIN Id: INE376G01013) is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. Biocon has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the U.S. and Europe. It is a leading global player for APIs including statins, immunosuppressants and specialty molecules. It also has a pipeline of promising novel assets in immunotherapy under development.
Biocon Biologics is a subsidiary of Biocon Ltd. It is uniquely positioned as a fully integrated ‘pure play’ biosimilars organization in the world and aspires to transform patient lives through innovative and inclusive healthcare solutions. The Company has a large portfolio of biosimilars under global clinical development with three of these commercialized in developed markets like EU, Australia, U.S. and Japan. For more information, visit www.biocon.com Follow-us on Twitter: @bioconlimited